[Federal Register Volume 76, Number 223 (Friday, November 18, 2011)]
[Pages 71567-71568]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-29866]



Centers for Disease Control and Prevention

Advisory Board on Radiation and Worker Health (ABRWH or Advisory 
Board), National Institute for Occupational Safety and Health (NIOSH)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42 
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC) 
announces the following meeting of the aforementioned committee:
    Board Public Meeting Times and Dates: (All times are Eastern Time):
    8:15 a.m.-5 p.m., December 7, 2011.
    8:15 a.m.-4 p.m., December 8, 2011.
    Public Comment Times and Dates (All times are Eastern Time):
    5 p.m.-6:30 p.m.,* December 7, 2011.
    * Please note that the public comment periods may end before the 
times indicated, following the last call for comments. Members of the 
public who wish to provide public comments should plan to attend public 
comment sessions at the start times listed.
    Place: Tampa Marriott Westshore, 1001 N. Westshore Blvd., Tampa, 
Florida 33607; Phone: (800) 564-3489; Fax: (813) 289-5464. Audio 
Conference Call via FTS Conferencing. The USA toll-free, dial-in number 
is 1-(866) 659-0537 with a pass code of 9933701.
    Status: Open to the public, limited only by the space available. 
The meeting space accommodates approximately 150 people.
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of probability of causation guidelines which have 
been promulgated by the Department of Health and Human Services (HHS) 
as a final rule, advice on methods of dose reconstruction which have 
also been promulgated by HHS as a final rule, advice on the scientific 
validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program, and advice on 
petitions to add classes of workers to the Special Exposure Cohort 
    In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements this 
responsibility for CDC. The charter was issued on August 3, 2001, 
renewed at appropriate intervals, and will expire on August 3, 2013.
    Purpose: This Advisory Board is charged with (a) providing advice 
to the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advising the Secretary on whether there is a class of employees at any 
Department of Energy facility who were exposed to radiation but for 
whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class.
    Matters To Be Discussed: The agenda for the Advisory Board meeting 
includes: NIOSH Program Update; Department of Labor (DOL) Program 
Update; Department of Energy (DOE) Program Update; Mound Plant Work 
Group Update; Pinellas Plant Site Profile Update; SEC petitions for: 
Weldon Spring, Hooker Electrochemical, Linde Ceramics Plant, Feed 
Materials Production Center (Fernald, Ohio), General Steel Industries; 
and Savannah River Site; SEC Petition Status Updates; Subcommittee and 
Work Group Reports; and Board Work Sessions.
    The agenda is subject to change as priorities dictate.
    In the event an individual cannot attend, written comments may be 
submitted in accordance with the redaction policy provided below. Any 
written comments received will be provided at the meeting and should be 
submitted to the contact person below well in advance of the meeting.
    Policy on Redaction of Board Meeting Transcripts (Public Comment): 
(1) If a person making a comment gives his or her name, no attempt will 
be made to redact that name. (2) NIOSH will take reasonable steps to 
ensure that individuals making public comment are aware of the fact 
that their comments (including their name, if provided) will appear in 
a transcript of the meeting posted on a public Web site. Such 
reasonable steps include: (a) A statement read at the start of each 
public comment period stating that transcripts will be posted and names 
of speakers will not be redacted; (b) A printed copy of the statement 
mentioned in (a) above will be displayed on the table where individuals 
sign up to make public comments; (c) A statement such as outlined in 
(a) above will also appear with the agenda for a Board Meeting when it 
is posted on the NIOSH Web site; (d) A statement such as in (a) above 
will appear in the Federal Register Notice that announces Board and 
Subcommittee meetings. (3) If an individual in making a statement 
reveals personal information (e.g., medical information) about 
themselves that information will not usually be redacted. The NIOSH 
FOIA coordinator will, however, review such revelations in accordance 
with the Freedom of

[[Page 71568]]

Information Act and the Federal Advisory Committee Act and if deemed 
appropriate, will redact such information. (4) All disclosures of 
information concerning third parties will be redacted. (5) If it comes 
to the attention of the DFO that an individual wishes to share 
information with the Board but objects to doing so in a public forum, 
the DFO will work with that individual, in accordance with the Federal 
Advisory Committee Act, to find a way that the Board can hear such 

Secretary, NIOSH, CDC, 1600 Clifton Road, MS E-20, Atlanta, GA 30333, 
telephone: (513) 533-6800, toll free: 1-(800) CDC-INFO, email: 
[email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register Notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention, and the Agency 
for Toxic Substances and Disease Registry.

    Dated: November 9, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention.
[FR Doc. 2011-29866 Filed 11-17-11; 8:45 am]